1. Koten JW, Neijt JP, Zonnenberg BA, Den Otter W. The difference between benign and malignant tumours explained with the 4-mutation
paradigm for carcinogenesis. Anticancer Res. 1993 Jul-Aug;13(4):1179-82.
2. Â Becker FF, editor. Cancer: a Comprehensive Treatise: 4. Biology of Tumours: Surfaces, Immunology and Comparative Pathology. New
York: Plenum Press; 1975. 439 p.
3. Haschek WM, Rousseaux CG, Wallig MA, Bolon B, Ochoa R (eds.). Haschek and Rousseauxâs Handbook of Toxicologic Pathology. 3rd ed.
Elsevier Inc.; 2013. Chapter 5, Carcinogenesis: Mechanisms and Manifestations; p. 107-46. DOI: 10.1016/B978-0-12-415759-0.00001-7.
4. Baba AI, Câtoi C. Comparative Oncology. Bucharest: The Publishing House of the Romanian Academy; 2007. Chapter 2, Carcinogenesis;
Chapter 3: Tumor cell morphology.
5. Nishida N, Yano H, Nishida T, Kamura T, Kojiro M. Angiogenesis in Cancer. Vasc Health Risk Manag. 2006 Sep;2(3):213-9. DOI: 10.2147/
vhrm. 2006.2.3.213.